KRMD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
KORU Medical Systems Inc (KRMD) is not a strong buy for a beginner, long-term investor at this time. While the company shows promising revenue growth, the declining net income, EPS, and gross margin, combined with bearish technical indicators and lack of significant positive catalysts, suggest holding off on investment for now. The stock may require further improvement in financials and technical trends to be a compelling buy.
The MACD is slightly positive but contracting, indicating weakening momentum. RSI is neutral at 38.765, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot point (4.229) with key resistance at 4.389 and support at 4.068. Overall, the technical indicators suggest a bearish trend.
Analyst B. Riley raised the price target to $8 from $7, maintaining a Buy rating, citing strong execution on strategic pillars.
Net income dropped significantly by -68.81% YoY, EPS declined by -66.67% YoY, and gross margin slightly decreased. No recent news or significant trading trends from insiders, hedge funds, or Congress. Technical indicators are bearish, and no AI Stock Picker or SwingMax signals are present.
In Q4 2025, revenue increased to $10,895,328 (up 23.27% YoY), but net income dropped to -$486,856 (-68.81% YoY). EPS decreased to -0.01 (-66.67% YoY), and gross margin slightly declined to 60.93% (-0.64% YoY).
B. Riley raised the price target to $8 from $7 and maintained a Buy rating, citing confidence in the company's strategic execution. However, no other analyst updates are available.
